Sun, Apr 20, 2014, 2:28 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Northwest Biotherapeutics, Inc. Message Board

  • mtaotter mtaotter Jun 13, 2013 1:06 PM Flag

    IMUC must be a serious buyout target by big pharma right now.

    Its the only way for them to stay in the game against NWBO, albeit, as runner-up. IMUC won't be able to compete by themselves unless they are purchased by big pharma. It will take a lot to launch and market a close but no cigar, albeit fantastic, second place treatment. The other big pharma in house immunotherapy treatments will get in line behind these 2 -- but the FDA will allow their development at breakneck speed.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I wouldn't sleep on IMUC. Although they do have a lot of leg work left to do, if they can continue to show good results, there will be a place for them. DCVax - L may be able to treat most of the population (pending results), but that doesn't mean it will work for everyone.

 
NWBO
5.88+0.18(+3.16%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST